Joubert syndrome

Joubert syndrome
Sumathipala, D., Strømme, P., Gilissen, C. et al. · CC BY 4.0 · source
Name	Joubert syndrome
Caption	Magnetic resonance image showing molar tooth sign
Specialty	Neurology, Medical genetics, Pediatrics
Symptoms	Hypotonia, ataxia, abnormal breathing, ocular motor apraxia
Onset	Infantile
Causes	Mutations in ciliary genes
Diagnosis	Clinical assessment, magnetic resonance imaging (molar tooth sign), genetic testing
Treatment	Supportive, multidisciplinary care

Joubert syndrome is a rare, genetically heterogeneous neurodevelopmental disorder characterized by a distinctive brainstem and cerebellar malformation visible on neuroimaging and a spectrum of clinical features including hypotonia, abnormal respiratory patterns, and oculomotor apraxia. First delineated in clinical case series, it has been linked to defects in primary cilia-related proteins and involves multiple organ systems in many patients. Management is multidisciplinary and often involves specialists from Pediatrics, Neurology, Ophthalmology, and Genetics.

Signs and symptoms

Individuals typically present in infancy with global hypotonia, delayed psychomotor development, and episodic abnormal breathing (alternating tachypnea and apnea) often noticed in the neonatal period; associated features include ataxia, dysarthria, and abnormal eye movements such as oculomotor apraxia and nystagmus. Many patients display facial dysmorphism and feeding difficulties requiring nutritional support and sometimes gastrostomy. Extra-neurological manifestations can involve renal cystic disease, hepatic fibrosis, and retinal dystrophy, producing signs that prompt referral to Nephrology, Hepatology, and Ophthalmology. Behavioral phenotypes and varying degrees of intellectual disability are common, leading to involvement with Developmental pediatrics, Child and adolescent psychiatry, and educational programs such as Special education services.

Genetics and pathophysiology

Joubert syndrome results from biallelic or, less commonly, dominant pathogenic variants in more than 40 genes encoding proteins of the primary cilium or centrosome; notable genes include CEP290, AHI1, TMEM67, NPHP1, and CC2D2A. These gene products are integral to ciliogenesis, intraflagellar transport, and ciliary signaling pathways such as Hedgehog and Wnt, which are critical for midline and cerebellar development. The characteristic "molar tooth sign" on magnetic resonance imaging reflects hypoplasia of the cerebellar vermis, thickened and elongated superior cerebellar peduncles, and a deep interpeduncular fossa—an anatomic consequence of disrupted neuronal migration and axonal decussation during embryogenesis. Genotype–phenotype correlations exist: for example, CEP290 variants are frequently associated with retinal degeneration and kidney disease, while TMEM67 mutations often feature hepatic fibrosis; these associations guide surveillance strategies by Clinical geneticists.

Diagnosis

Diagnosis is based on clinical findings and confirmatory neuroimaging demonstrating the molar tooth sign on axial magnetic resonance imaging, supplemented by targeted or broad genetic testing such as gene panels, exome sequencing, or chromosomal microarray performed by diagnostic laboratories and reviewed by Clinical laboratory scientists and Medical geneticists. Ancillary evaluations include comprehensive ophthalmologic examination with electroretinography for retinal dystrophy, renal ultrasound and functional studies for nephronophthisis or cystic renal disease, and liver imaging and function tests for congenital hepatic fibrosis evaluated by Hepatology. Differential diagnosis requires exclusion of other cerebellar vermis hypoplasias and syndromes with overlapping features; multidisciplinary case review panels including Neuroradiology and Pediatric neurology often aid interpretation. Genetic counseling by certified Genetic counselors is recommended for families to discuss recurrence risks, reproductive options, and prenatal testing or preimplantation genetic diagnosis coordinated with Reproductive endocrinology services.

Management and treatment

There is no disease-modifying therapy; management is supportive and individualized, coordinated by a multidisciplinary team including Physical therapy, Occupational therapy, Speech–language pathology, and specialty clinics in Pediatric neurology, Nephrology, Ophthalmology, and Hepatology. Respiratory support for neonatal apnea and feeding interventions (e.g., gastrostomy) may be necessary, while orthopedic care addresses scoliosis and contractures often managed by Orthopedic surgery. Surveillance protocols based on genotype and phenotype guide periodic assessments: renal monitoring for cystic disease, ophthalmologic screening for progressive retinal dystrophy, and liver evaluation for portal hypertension or fibrosis, with timely referral for transplant services such as Nephrology-led renal replacement therapy or Transplant surgery when indicated. Emerging avenues include preclinical studies targeting ciliary function and gene-specific approaches explored within translational centers and academic consortia affiliated with institutions like National Institutes of Health-funded networks; enrollment in clinical trials and patient registries is often facilitated by patient advocacy organizations and specialized research centers.

Prognosis and complications

Prognosis is highly variable and depends on the severity of neurologic impairment and the presence and progression of multi-organ involvement such as renal failure, hepatic fibrosis with portal hypertension, or progressive retinal degeneration leading to vision loss. Many individuals achieve independent mobility and communication with therapies, while others have significant intellectual disability and complex medical needs requiring lifelong multidisciplinary care; transition to adult services involves coordination with Internal medicine and subspecialty providers. Complications include chronic kidney disease potentially progressing to end-stage renal disease, liver failure or complications of portal hypertension, respiratory complications in infancy, and vision impairment; these may necessitate interventions ranging from dialysis and renal transplantation to liver-directed therapies and supportive ophthalmologic care. Ongoing surveillance, early intervention, and access to genetic counseling and specialized multidisciplinary clinics improve outcomes and family planning decisions.

Category:Rare genetic disorders